BE513337A - - Google Patents
Info
- Publication number
- BE513337A BE513337A BE513337DA BE513337A BE 513337 A BE513337 A BE 513337A BE 513337D A BE513337D A BE 513337DA BE 513337 A BE513337 A BE 513337A
- Authority
- BE
- Belgium
- Prior art keywords
- cortisone
- tricarballylate
- sep
- salt
- alkaline earth
- Prior art date
Links
- 229960004544 cortisone Drugs 0.000 claims description 41
- MFYSYFVPBJMHGN-ZPOLXVRWSA-N Cortisone Chemical compound O=C1CC[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 MFYSYFVPBJMHGN-ZPOLXVRWSA-N 0.000 claims description 40
- KQTIIICEAUMSDG-UHFFFAOYSA-K tricarballylate Chemical compound [O-]C(=O)CC(C([O-])=O)CC([O-])=O KQTIIICEAUMSDG-UHFFFAOYSA-K 0.000 claims description 31
- 239000011780 sodium chloride Substances 0.000 claims description 18
- 229910052784 alkaline earth metal Inorganic materials 0.000 claims description 13
- -1 alkaline earth metal salt Chemical class 0.000 claims description 10
- 150000003839 salts Chemical class 0.000 claims description 9
- 238000000034 method Methods 0.000 claims description 8
- 229910052783 alkali metal Inorganic materials 0.000 claims description 6
- JUJWROOIHBZHMG-UHFFFAOYSA-N pyridine Chemical group C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 6
- 150000001340 alkali metals Chemical class 0.000 claims description 5
- 239000003795 chemical substances by application Substances 0.000 claims description 5
- 239000002585 base Substances 0.000 claims description 4
- 238000006243 chemical reaction Methods 0.000 claims description 2
- 230000000875 corresponding Effects 0.000 claims 2
- 150000007529 inorganic bases Chemical class 0.000 claims 1
- 159000000000 sodium salts Chemical class 0.000 claims 1
- 229920001098 polystyrene-block-poly(ethylene/propylene) Polymers 0.000 description 22
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 150000001875 compounds Chemical class 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 210000002381 Plasma Anatomy 0.000 description 4
- KQTIIICEAUMSDG-UHFFFAOYSA-N Propane-1,2,3-tricarboxylic acid Chemical compound OC(=O)CC(C(O)=O)CC(O)=O KQTIIICEAUMSDG-UHFFFAOYSA-N 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- ITRJWOMZKQRYTA-RFZYENFJSA-N Cortisone acetate Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(=O)COC(=O)C)(O)[C@@]1(C)CC2=O ITRJWOMZKQRYTA-RFZYENFJSA-N 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 229960003290 cortisone acetate Drugs 0.000 description 3
- 150000001887 cortisones Chemical class 0.000 description 3
- 238000005755 formation reaction Methods 0.000 description 3
- KEAYESYHFKHZAL-UHFFFAOYSA-N sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N HCl Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 238000007710 freezing Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- OKKJLVBELUTLKV-UHFFFAOYSA-N methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 230000001225 therapeutic Effects 0.000 description 2
- 206010003246 Arthritis Diseases 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical class OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L Calcium hydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- 210000003491 Skin Anatomy 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 150000001242 acetic acid derivatives Chemical class 0.000 description 1
- 230000001476 alcoholic Effects 0.000 description 1
- 150000001342 alkaline earth metals Chemical class 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 239000000920 calcium hydroxide Substances 0.000 description 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 230000005591 charge neutralization Effects 0.000 description 1
- ALEXXDVDDISNDU-JZYPGELDSA-N cortisol 21-acetate Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(=O)COC(=O)C)(O)[C@@]1(C)C[C@@H]2O ALEXXDVDDISNDU-JZYPGELDSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drugs Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 229960001067 hydrocortisone acetate Drugs 0.000 description 1
- 150000004679 hydroxides Chemical class 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 230000003522 irritant Effects 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 230000001264 neutralization Effects 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 230000003472 neutralizing Effects 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000000699 topical Effects 0.000 description 1
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Cosmetics (AREA)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE513337A true BE513337A (xx) |
Family
ID=151498
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE513337D BE513337A (xx) |
Country Status (1)
| Country | Link |
|---|---|
| BE (1) | BE513337A (xx) |
-
0
- BE BE513337D patent/BE513337A/fr unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CH651561A5 (fr) | Derives des nor-tropane et granatane et leur procede de preparation. | |
| CA1325423C (fr) | Procede de synthese de l'azido-3'desozy-3'-thymidine et analogues | |
| CH631151A5 (fr) | Procede de preparation d'hemiacetal-esters de l'acide glyoxylique. | |
| BE513337A (xx) | ||
| DE60204681T2 (de) | Verfahren zur herstellung von 2-[4-(2,2,-dihalocyclopropyl)phenoxy]-alkansäuren und ihre estern | |
| CA1091249A (fr) | Procede de preparation de nouvelles n-acyl glutamines et les nouveaux produits ainsi obtenus | |
| EP0012072B1 (fr) | Bêta-lactones dérivées de l'acide 2-hydroxy cyclopentane carboxylique, procédé pour leur préparation et compositions pharmaceutiques les renfermant | |
| EP0002151B1 (fr) | Procédé de synthèse d'esters parachlorobenzoylphenoxy isobutyriques | |
| JP2005075798A (ja) | アダマンチルエステル化合物の製造方法 | |
| FR2663024A1 (fr) | Procede de preparation d'acide (2-hydroxyphenyl) acetique. | |
| CH438347A (fr) | Procédé de préparation de nouveaux dérivés colchiciques | |
| BE489398A (xx) | ||
| BE818471A (fr) | Procede pour preparer des 1-aralkyl-4-amino-methylpiperidine-4-ols | |
| FR2491471A1 (fr) | Benzoxazolinones substituees, leur preparation et leur application en therapeutique | |
| CH411820A (fr) | Procédé de préparation de nouveaux composés hépariniques utilisables, notamment, pour le traitement des troubles de la coagulabilité sanguine | |
| EP0017523A1 (fr) | Nouveaux dérivés du dithiépinno (1,4)(2,3-c)pyrrole, leur préparation et les médicaments qui les contiennent | |
| BE832868A (fr) | Derives de l'abietamide | |
| FR2498449A1 (fr) | Acides halogeno biphenyl carboxyliques et leurs sels utiles en therapeutique | |
| CH529744A (fr) | Procédé de préparation de dérivés de l'acide phénylacétique | |
| BE461847A (xx) | ||
| BE517072A (xx) | ||
| BE551657A (xx) | ||
| CH402842A (fr) | Procédé de préparation de nouveaux dérivés de l'héparine | |
| BE484261A (xx) | ||
| CH342579A (fr) | Procédé de préparation de O-peptides |